Interventional Therapies
Enteral Stents
Mitra's enteral stents are indicated for palliative treatment of gastroduodenal obstructions and colonic strictures caused by malignant neoplasms.
Malignant obstructions of the gastrointestinal tract can severely limit a patient's ability to eat and maintain normal digestive function. Mitra's enteral stents are designed to restore luminal patency and support palliative treatment.
The range addresses gastroduodenal obstructions and colonic strictures caused by malignant neoplasms, with dedicated pyloric and colonic configurations.
Product Range
Uncovered Pyloric Stent
For palliative treatment of gastroduodenal obstructions caused by malignant neoplasms.
Uncovered Colonic Stent
For palliative treatment of colonic strictures caused by malignant neoplasms.
HONTO Covered Colonic Stent
Covered colonic configuration for palliative treatment of malignant colonic strictures, designed to resist tumour ingrowth.
Applications
- 01
Gastroduodenal Obstructions
Palliative treatment of obstructions caused by malignant neoplasms.
- 02
Colonic Strictures
Palliative treatment of colonic strictures caused by malignant neoplasms.
Specifications
- Uncovered Pyloric Stent
- Available
- Uncovered Colonic Stent
- Available
- HONTO Covered Colonic Stent
- Available
Dimensional specifications available on request and to be validated against approved product brochures.
Need Details on Mitra Enteral Stents?
Connect with Mitra for product guidance, catalogue access, and clinical product information.